Neuropeptides and anxiety disorders

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• Anxiety disorders are complex conditions with multifactorial etiologies.
• Neuropeptides are signaling molecules in the brain that influence mood and behavior.
• Several neuropeptides have been implicated in stress and anxiety responses.

Purpose of the Study:

• To review the potential role of four key neuropeptides in the pathogenesis of anxiety disorders.
• To synthesize existing neuroanatomical, electrophysiological, animal, and human data.
• To identify neuropeptides with the strongest evidence linking them to anxiety.

Main Methods:

• Literature review of neuroanatomical and electrophysiological studies.
• Analysis of animal experimental findings.
• Evaluation of human research data, including clinical studies.

Main Results:

• Adrenocorticotropic hormone (ACTH), corticotropin-releasing hormone (CRH), and neuropeptide Y (NPY) have proposed mechanisms in the brain related to anxiety.
• Most research findings are derived from animal models.
• Cholecystokinin (CCK) shows increasing evidence, including human studies, for a role in anxiety pathogenesis.

Conclusions:

• Cholecystokinin (CCK) is the most promising neuropeptide studied, with growing human evidence supporting its role in anxiety disorders.
• The involvement of ACTH, CRH, and NPY in anxiety pathogenesis requires further establishment through future research.
• Neuropeptides represent a potential therapeutic target for anxiety disorders, warranting continued investigation.